BridgeBio Pharma LLC, 10% Owner at Eidos Therapeutics, Inc. (EIDX), bought 3,957,696 shares at $14.01 ($58.1M) on 2018-12-05, disclosed to the SEC on 2018-12-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.50 | 1,750,000 | $27.1M | 46.7% |
| 2 | $14.01 | 1,103,848 | $15.5M | 26.6% |
| 3 | $14.01 | 1,103,848 | $15.5M | 26.6% |
| Total | $14.67 avg | 3,957,696 | $58.1M | 100% |
| Filing → |
| EIDX | BUY | 2018-12-13 | $505K | — | Filing → |
| EIDX | BUY | 2018-12-13 | $542K | — | Filing → |
| EIDX | SELL | 2018-12-12 | $542K | — | Filing → |